• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移后播散阶段的固有和获得性免疫监视。

Innate and acquired immune surveillance in the postdissemination phase of metastasis.

机构信息

Department of Anatomy and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.

出版信息

FEBS J. 2018 Feb;285(4):654-664. doi: 10.1111/febs.14325. Epub 2017 Nov 24.

DOI:10.1111/febs.14325
PMID:29131550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5826884/
Abstract

Metastasis is responsible for the majority of death in cancer patients. Of the different steps in the metastasis cascade, the postdissemination phase is perhaps one of the least understood. Many factors, both from the disseminated tumor cells and the microenvironment, impact the success of the metastatic outgrowth. In this article, we discuss the interactions between colonizing cancer cells and immune cells in the period between vascular arrest in a secondary organ and metastatic outgrowth. We address the ambiguity in the findings of current research regarding the role of immune cells in regulating the metastatic microenvironment, and their hand in determining cancer cell fate.

摘要

转移是癌症患者死亡的主要原因。在转移级联的不同步骤中,播散后阶段也许是了解最少的阶段之一。许多因素,包括来自播散的肿瘤细胞和微环境,都会影响转移生长的成功。在本文中,我们讨论了在次级器官血管阻塞与转移生长之间的时期,定植癌细胞与免疫细胞之间的相互作用。我们讨论了当前研究中关于免疫细胞在调节转移微环境中的作用以及它们在决定癌细胞命运方面的作用的研究结果中的模糊性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dec/5826884/0cda3a97030f/nihms919689f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dec/5826884/0cda3a97030f/nihms919689f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3dec/5826884/0cda3a97030f/nihms919689f1.jpg

相似文献

1
Innate and acquired immune surveillance in the postdissemination phase of metastasis.转移后播散阶段的固有和获得性免疫监视。
FEBS J. 2018 Feb;285(4):654-664. doi: 10.1111/febs.14325. Epub 2017 Nov 24.
2
Circulating and disseminated tumour cells - mechanisms of immune surveillance and escape.循环肿瘤细胞和播散肿瘤细胞——免疫监视和逃逸的机制。
Nat Rev Clin Oncol. 2017 Mar;14(3):155-167. doi: 10.1038/nrclinonc.2016.144. Epub 2016 Sep 20.
3
Control of Metastasis by NK Cells.自然杀伤细胞对转移的控制。
Cancer Cell. 2017 Aug 14;32(2):135-154. doi: 10.1016/j.ccell.2017.06.009.
4
Roles of the immune system in cancer: from tumor initiation to metastatic progression.免疫系统在癌症中的作用:从肿瘤起始到转移进展。
Genes Dev. 2018 Oct 1;32(19-20):1267-1284. doi: 10.1101/gad.314617.118.
5
[Immune system and tumors].[免疫系统与肿瘤]
Ann Pathol. 2017 Feb;37(1):11-17. doi: 10.1016/j.annpat.2016.12.004. Epub 2017 Jan 31.
6
Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.肿瘤诱导的 T 细胞免疫抑制的机制及对抗这些效应的治疗方法。
Arch Pharm Res. 2015 Aug;38(8):1415-33. doi: 10.1007/s12272-015-0566-y. Epub 2015 Jan 30.
7
The Contribution of the Immune System in Bone Metastasis Pathogenesis.免疫系统在骨转移发病机制中的贡献。
Int J Mol Sci. 2019 Feb 25;20(4):999. doi: 10.3390/ijms20040999.
8
Platelet-Mediated Protection of Cancer Cells From Immune Surveillance - Possible Implications for Cancer Immunotherapy.血小板介导的癌细胞免疫逃避及其对癌症免疫治疗的启示
Front Immunol. 2021 Mar 10;12:640578. doi: 10.3389/fimmu.2021.640578. eCollection 2021.
9
Effect of tumor cells and tumor microenvironment on NK-cell function.肿瘤细胞和肿瘤微环境对 NK 细胞功能的影响。
Eur J Immunol. 2014 Jun;44(6):1582-92. doi: 10.1002/eji.201344272.
10
Influence of Innate Immunity on Cancer Cell Stemness.先天免疫对肿瘤干细胞干性的影响。
Int J Mol Sci. 2020 May 9;21(9):3352. doi: 10.3390/ijms21093352.

引用本文的文献

1
Circulating immune cells exhibit distinct traits linked to metastatic burden in breast cancer.循环免疫细胞表现出与乳腺癌转移负担相关的独特特征。
Breast Cancer Res. 2025 May 8;27(1):73. doi: 10.1186/s13058-025-01982-2.
2
Towards understanding cancer dormancy over strategic hitching up mechanisms to technologies.通过将战略搭便车机制与技术相结合来理解癌症休眠。
Mol Cancer. 2025 Feb 14;24(1):47. doi: 10.1186/s12943-025-02250-9.
3
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC.

本文引用的文献

1
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and Beyond.FDA 批准概要:帕博利珠单抗治疗转移性非小细胞肺癌:一线治疗及以上。
Oncologist. 2017 Nov;22(11):1392-1399. doi: 10.1634/theoncologist.2017-0078. Epub 2017 Aug 23.
2
Control of Metastasis by NK Cells.自然杀伤细胞对转移的控制。
Cancer Cell. 2017 Aug 14;32(2):135-154. doi: 10.1016/j.ccell.2017.06.009.
3
Immunotherapy targeting immune check-point(s) in brain metastases.脑转移瘤的免疫检查点靶向治疗。
癌症中功能失调性髓系造血的多方面问题及治疗前景,重点关注肝癌
Biomolecules. 2024 Nov 24;14(12):1496. doi: 10.3390/biom14121496.
4
Design Principles of an Engineered Metastatic Niche for Monitoring of Cancer Progression.用于监测癌症进展的工程化转移微环境的设计原则
Biotechnol Bioeng. 2025 Mar;122(3):631-641. doi: 10.1002/bit.28895. Epub 2024 Dec 3.
5
Systems Biology and Cytokines Potential Role in Lung Cancer Immunotherapy Targeting Autophagic Axis.系统生物学与细胞因子在靶向自噬轴的肺癌免疫治疗中的潜在作用
Biomedicines. 2023 Oct 5;11(10):2706. doi: 10.3390/biomedicines11102706.
6
Fluid shear stress enhances natural killer cell's cytotoxicity toward circulating tumor cells through NKG2D-mediated mechanosensing.流体剪切应力通过NKG2D介导的机械传感增强自然杀伤细胞对循环肿瘤细胞的细胞毒性。
APL Bioeng. 2023 Aug 11;7(3):036108. doi: 10.1063/5.0156628. eCollection 2023 Sep.
7
Harnessing NK Cells to Control Metastasis.利用自然杀伤细胞控制转移。
Vaccines (Basel). 2022 Nov 25;10(12):2018. doi: 10.3390/vaccines10122018.
8
The clinical significance of integrin subunit alpha V in cancers: from small cell lung carcinoma to pan-cancer.整合素亚单位α V 在癌症中的临床意义:从小细胞肺癌到泛癌症。
BMC Pulm Med. 2022 Aug 4;22(1):300. doi: 10.1186/s12890-022-02095-8.
9
Neurodevelopmental disorders, immunity, and cancer are connected.神经发育障碍、免疫和癌症之间存在关联。
iScience. 2022 May 30;25(6):104492. doi: 10.1016/j.isci.2022.104492. eCollection 2022 Jun 17.
10
The Immune-Enhancing Properties of Hwanglyeonhaedok-Tang-Mediated Biosynthesized Gold Nanoparticles in Macrophages and Splenocytes.黄莲解毒汤介导生物合成金纳米粒子对巨噬细胞和脾细胞的免疫增强特性。
Int J Nanomedicine. 2022 Jan 29;17:477-494. doi: 10.2147/IJN.S338334. eCollection 2022.
Cytokine Growth Factor Rev. 2017 Aug;36:33-38. doi: 10.1016/j.cytogfr.2017.07.002. Epub 2017 Jul 13.
4
Increased Infiltration of Natural Killer and T Cells in Colorectal Liver Metastases Improves Patient Overall Survival.自然杀伤细胞和T细胞在结直肠癌肝转移中的浸润增加可改善患者的总生存期。
J Gastrointest Surg. 2017 Aug;21(8):1226-1236. doi: 10.1007/s11605-017-3446-6. Epub 2017 May 23.
5
Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis.正常和癌性乳腺干细胞通过miR-199a-LCOR轴逃避干扰素诱导的限制。
Nat Cell Biol. 2017 Jun;19(6):711-723. doi: 10.1038/ncb3533. Epub 2017 May 22.
6
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.肿瘤相关巨噬细胞的PD-1表达抑制吞噬作用和肿瘤免疫。
Nature. 2017 May 25;545(7655):495-499. doi: 10.1038/nature22396. Epub 2017 May 17.
7
Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response.器官转移中循环肿瘤细胞的特征、预后及T淋巴细胞介导的免疫反应
Onco Targets Ther. 2017 May 4;10:2413-2424. doi: 10.2147/OTT.S130087. eCollection 2017.
8
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.双重血管生成素-2 和 VEGFA 抑制引发抗肿瘤免疫,这种免疫可被 PD-1 检查点阻断增强。
Sci Transl Med. 2017 Apr 12;9(385). doi: 10.1126/scitranslmed.aak9670.
9
Prospects for combining targeted and conventional cancer therapy with immunotherapy.靶向和常规癌症治疗与免疫疗法联合的前景。
Nat Rev Cancer. 2017 May;17(5):286-301. doi: 10.1038/nrc.2017.17. Epub 2017 Mar 24.
10
Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages.IIa类组蛋白去乙酰化酶抑制通过抗肿瘤巨噬细胞减少乳腺肿瘤和转移。
Nature. 2017 Mar 16;543(7645):428-432. doi: 10.1038/nature21409. Epub 2017 Mar 8.